Produkty 1175-06-0

CAS 1175-06-0 występuje w naszej ofercie pod nazwami: 6-Keto Cholestanol, >95% (HPLC), 6–Ketocholestanol, 6-Keto cholestanol, 6-Ketocholestanol, 98%, 98%, 6-Ketocholestanol, 98.68%. Oferty producentów: TRC, GLPBio, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 1g, 2,5g, 250mg, 10mg, 5mg, 2g, 10mM/1mL, 5 mg.

6-Keto Cholestanol, >95% (HPLC)
TRC
  • opakowanie: 1g, 2,5g, 250mg
  • Warianty: 3
Zobacz produkt
6–Ketocholestanol
GLPBio
  • opakowanie: 10mg, 5mg
  • Warianty: 2
od 1088,49
Zobacz produkt
6-Keto cholestanol
Biosynth
  • opakowanie: 1g, 2g
  • Warianty: 2
Zobacz produkt
6-Ketocholestanol, 98%, 98%
Chemat
  • opakowanie: 5mg, 10mg
  • Warianty: 2
od 1773,20
Zobacz produkt
6-Ketocholestanol, 98.68%
MedChemExpress
  • opakowanie: 10mM/1mL, 5 mg, 10 mg
  • Warianty: 3
od 886,26
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,5S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-6-one (CAS 1175-06-0) to związek chemiczny o wzorze sumarycznym C27H46O2 i masie molowej 402.7 g/mol. Nazwa systematyczna IUPAC: (3S,5S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-6-one. InChIKey: JQMQKOQOLPGBBE-ZNCJEFCDSA-N.

Dane identyfikacyjne
Wzór sumarycznyC27H46O2
Masa molowa402.7 g/mol
Nazwa IUPAC(3S,5S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-6-one
InChIKeyJQMQKOQOLPGBBE-ZNCJEFCDSA-N
SMILESC[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=O)[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C

Dane obliczone przez PubChem (NCBI)

Synonimy: 6-Ketocholestanol, 6-Oxocholestanol, 5alpha-Cholestan-3beta-ol-6-one, 5alpha-cholestan-6-oxo-3beta-ol, Cholestan-6-one, 3-hydroxy-, (3beta,5alpha)-, 5alpha-Cholestan-6-one, 3beta-hydroxy-, 6-ketocholestan-3beta-ol, 6-Keto Cholestanol, 5.alpha.-Cholestan-6-one, 3.beta.-hydroxy-, Cholestan-6-one, 3-hydroxy-, (3.beta.,5.alpha.)-
Powiązane formy tego związku
(3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,5,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-6-one C27H46O2
Izomery (ten sam wzór sumaryczny)
heptacosa-10,12-diynoic acid C27H46O2
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-5-hydroxy-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O2
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-7,7,7-trideuterio-6-hydroxy-6-(trideuteriomethyl)heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O2
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,6R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O2
(2R)-2,8-dimethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-ol C27H46O2
(3S,8R,9S,10R,12S,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol C27H46O2
(2S,3R,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-2,3-diol C27H46O2
(1S,2R,5S,7R,9S,11S,12S,15R,16R)-2,16-dimethyl-15-[(2R)-6-methylheptan-2-yl]-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadecan-5-ol C27H46O2
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6,7,7,7-tetradeuterio-6-[dideuterio(hydroxy)methyl]heptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O2
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R,5S)-5-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol C27H46O2
(3S,7S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol C27H46O2